| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/18/2007 | WO2007056473A2 Acoustically controlled reaction device |
| 05/18/2007 | WO2007056442A1 Compositions of stabilized ramipril in combination with another active agent |
| 05/18/2007 | WO2007056424A2 Controlled-release emulsion compositions |
| 05/18/2007 | WO2007056309A2 Fluid delivery devices, systems and methods |
| 05/18/2007 | WO2007056205A2 Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
| 05/18/2007 | WO2007056185A2 Process of making ceramic, mineral and metal beads from powder |
| 05/18/2007 | WO2007056125A2 Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances |
| 05/18/2007 | WO2007056068A2 Macrocyclic formulations for transmembrane drug delivery |
| 05/18/2007 | WO2007055887A1 Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same |
| 05/18/2007 | WO2007055696A1 Coated pharmaceutical composition for buccal release which comprises a consumable centre and a medicament-containing coating |
| 05/18/2007 | WO2007055428A1 Intraorally rapidly disintegrating tablet |
| 05/18/2007 | WO2007055427A1 Intraorally rapidly disintegrating tablet |
| 05/18/2007 | WO2007055329A1 Controlled release solid preparation |
| 05/18/2007 | WO2007055327A1 Jelly composition |
| 05/18/2007 | WO2007055279A1 Iontophoresis preparation |
| 05/18/2007 | WO2007055176A1 Pressure-sensitive adhesive base and adhesive patch of percutaneous absorption type |
| 05/18/2007 | WO2007055044A1 Promoter for recovery from anesthesia |
| 05/18/2007 | WO2007054976A2 Lipid based controlled release pharmaceutical composition |
| 05/18/2007 | WO2007054968A2 Novel pharmaceutical compositions of clopidogrel mesylate |
| 05/18/2007 | WO2007054958A1 A stable formulation for treatment of respiratory disorder |
| 05/18/2007 | WO2007054782A1 Stabilized lanthanum carbonate compositions |
| 05/18/2007 | WO2007054498A1 Aerosolformulation for inhalation |
| 05/18/2007 | WO2007054378A1 Anti-misuse microparticulate oral pharmaceutical form |
| 05/18/2007 | WO2007054373A1 Composition and its use for the manufacture of a medicament for treating, prophylactically treating, preventing cancer and/or infections in the urinary tract |
| 05/18/2007 | WO2007054182A2 Nanoparticles used as contrasting agents in magnetic resonance imaging |
| 05/18/2007 | WO2007053982A1 Chinese pharmaceutical compositions for treating epidemic cerebrospinal meningitis and processes for preparation thereof |
| 05/18/2007 | WO2007053923A2 Solid pharmaceutical composition comprising agglomerate nanoparticles and a process for producing the same |
| 05/18/2007 | WO2007053904A1 Process to control particle size |
| 05/18/2007 | WO2007053902A1 Method of treating parasites |
| 05/18/2007 | WO2007035941A3 Transdermal galantamine delivery system |
| 05/18/2007 | WO2007033239A3 Nanoparticulate tadalafil formulations |
| 05/18/2007 | WO2007028513A3 Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient |
| 05/18/2007 | WO2007025094A3 Stabilized and preserved ketotifen ophthalmic compositions |
| 05/18/2007 | WO2007021964A3 Intravesical drug delivery device and method |
| 05/18/2007 | WO2007018622A3 Vaginal treatment composition |
| 05/18/2007 | WO2007014566A3 Microcapsules and their use |
| 05/18/2007 | WO2006138641A3 Manufacturing process for tigecycline |
| 05/18/2007 | WO2006136916A3 Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same |
| 05/18/2007 | WO2006127639A3 Process for preparation of isotonic aqueous injection of ropivacaine |
| 05/18/2007 | WO2006127559A3 Indicia bearing package for a deliery system comprising an edible composition |
| 05/18/2007 | WO2006121669A3 Coating of medical devices with solids |
| 05/18/2007 | WO2006118948A3 Therapeutic compositions |
| 05/18/2007 | WO2006108637A3 Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof |
| 05/18/2007 | WO2006097286A3 Orally-administered product for the prevention and treatment of nappy rash |
| 05/18/2007 | WO2006091719A3 Compositions and methods enhancing transdermal delivery of drugs and biologics |
| 05/18/2007 | WO2006089207A3 Drugs with improved hydrophobicity for incorporation in medical devices |
| 05/18/2007 | WO2006089012A3 Device for delivery of trpv1 agonists |
| 05/18/2007 | WO2006055954A3 Steroid formulation and methods of treatment using same |
| 05/18/2007 | WO2004103208A3 Manufacture and use of implantable reticulated elastomeric matrices |
| 05/18/2007 | WO2003076594A3 Genomic screen for epigenetically silenced tumor suppressor genes |
| 05/18/2007 | CA2634181A1 Human growth hormone patch formulations |
| 05/18/2007 | CA2629810A1 Film-forming resins as a carrier for topical application of pharmacologically active agents |
| 05/18/2007 | CA2629487A1 Intraorally rapidly disintegrating tablet |
| 05/18/2007 | CA2628955A1 Compositions of stabilized ramipril in combination with another active agent |
| 05/18/2007 | CA2628848A1 Compositions and methods for treating thrombocytopenia |
| 05/18/2007 | CA2628716A1 Process to control particle size |
| 05/18/2007 | CA2628305A1 Jelly composition |
| 05/18/2007 | CA2628289A1 Herbal composition for weight management |
| 05/18/2007 | CA2627726A1 Aerosolformulation for inhalation |
| 05/18/2007 | CA2627058A1 Anti-misuse microparticulate oral pharmaceutical form |
| 05/18/2007 | CA2626894A1 Stabilized lanthanum carbonate compositions |
| 05/18/2007 | CA2620219A1 Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same |
| 05/18/2007 | CA2610662A1 Foamable vehicle and pharmaceutical compositions thereof |
| 05/17/2007 | US20070112593 Selection system, dispensing system and treatment with a one-a-day combination pill for hypertension, hypercholesterolemia, hypertriglyceridemia and anti-platelet treatment |
| 05/17/2007 | US20070112327 Methods and compositions for treating a renal disease condition in a subject |
| 05/17/2007 | US20070112316 Cochlear drug delivery system and method |
| 05/17/2007 | US20070112308 Apparatus for delivering foam |
| 05/17/2007 | US20070112184 shear stress treatment, drying; for use in dairy products, meats, and dessert gels as well as toothpaste formulations, cosmetics, paints, films and delivery capsules |
| 05/17/2007 | US20070112176 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 05/17/2007 | US20070112127 Oil based blends of interpolymers of ethylene/alpha-olefins |
| 05/17/2007 | US20070112114 Pharmaceutical metered dose inhaler and methods relating thereto |
| 05/17/2007 | US20070112064 Nucleic acid antioxidant compositions, methods for obtaining such compositions and formulations thereof |
| 05/17/2007 | US20070110962 Three-dimensional gels that have microscale features |
| 05/17/2007 | US20070110817 Biological active blood serum obtained by electrostimulation |
| 05/17/2007 | US20070110816 Method of coating nanoparticles |
| 05/17/2007 | US20070110815 Micronised azodicarbonamide, and the preparation and use thereof |
| 05/17/2007 | US20070110814 Bioactive polypeptide conjugated to the sulfate group; sustained release; alginate sulfate or sulfated hyaluronan conjugated to e.g. insulin, glatiramer acetate, antithrombin III, interferon gamma , IGF, somatostatin, luteinizing hormone-releasing hormone, erythropoietin, interleukins |
| 05/17/2007 | US20070110813 Polycation-polyanion complexes, compositions and methods of use thereof |
| 05/17/2007 | US20070110812 Ophthalmic composition for dry eye therapy |
| 05/17/2007 | US20070110811 Methods for reducing the mitogenicity of lectin compositions |
| 05/17/2007 | US20070110810 Transdermal drug delivery systems, devices, and methods employing hydrogels |
| 05/17/2007 | US20070110809 Stabilised compositions |
| 05/17/2007 | US20070110808 Extended release osmo-microsealed formulation |
| 05/17/2007 | US20070110807 Delayed release tablet with defined core geometry |
| 05/17/2007 | US20070110806 Core contains acid-unstable drug and disintegrant, and release-controlling coating contains water-insoluble polymer, an enteric polymer and hydrophobic wax; capsules |
| 05/17/2007 | US20070110805 Modified-release pharmaceutical compositions |
| 05/17/2007 | US20070110804 Drug polymer complexes |
| 05/17/2007 | US20070110803 Pharmaceutical formulation comprising levothyroxine sodium |
| 05/17/2007 | US20070110802 Wet granulation process |
| 05/17/2007 | US20070110801 Method for the diffusion of molecules which are insoluble in an aqueous medium and composition using said method |
| 05/17/2007 | US20070110800 Pharmaceutical composition having uniform drug distribution and potency |
| 05/17/2007 | US20070110799 Film-forming starchy composition |
| 05/17/2007 | US20070110798 Liposomes useful for drug delivery to the brain |
| 05/17/2007 | US20070110797 Methods and Compositions For Topical Wound Treatment |
| 05/17/2007 | US20070110795 Biocompatible; thin flexible film or porous membrane; topical applying to injuried organ; mixture of chtiosan and an acid |
| 05/17/2007 | US20070110794 Delivery system for topical medications |
| 05/17/2007 | US20070110793 Disintegrating digestive tract barrier |
| 05/17/2007 | US20070110792 Cosmetic or dermatological article comprising a medium that is soluble in water |
| 05/17/2007 | US20070110791 Cleansing lotion with moisturising, protecting and odor controlling agents and cloth comprising said lotion |
| 05/17/2007 | US20070110790 Steam-generating warming article |